SanBio Company Limited
サンバイオ株式会社
Valuation
Fundamental ratios for the latest reported period.
Ticker: 4592
FY2025 (Jan 2026) · J-GAAP · consolidated Source: filing S100XZTW
FY = fiscal year, named by the calendar year it starts in; the month in brackets is when it ends (FY2025 ends Mar 2026 for a March year-end). FY2025 (Jan 2026) runs Feb 1, 2025 – Jan 31, 2026.
| Gross margin | —Not in the filing: revenue, gross profit / cost of sales |
|---|---|
| Operating margin | —Not in the filing: revenue |
| Net margin | —Not in the filing: revenue |
| Return on equity | -51.6%Includes one-off items (e.g. gains on negative goodwill) |
| Return on assets | -40.3% |
| Revenue growth (YoY) | —Not in the filing: revenue |
| EPS (basic) | −¥52.55 |
| EPS growth (YoY) | —Base is zero or negative |
| Current ratio | 28.99x |
| Equity ratio | 85.4% |
| Book value / share | ¥170.93 |
| Free cash flow | −¥3.8B |